Corrigendum: Regulatory T cells targeting a pathogenic MHC class II: insulin peptide epitope postpone spontaneous autoimmune diabetes

Affiliations

• ¹ Diabetes Center, Indiana Biosciences Research Institute, Indianapolis, IN, United States.
• ² Department of Medicine, Endocrinology, Diabetes & Metabolism, Baylor College of Medicine, Houston, TX, United States.
• ³ Department of Biostatistics and Health Data Science, School of Medicine, Indiana University, Indianapolis, IN, United States.
• ⁴ Melvin and Bren Simon Comprehensive Cancer Center, Experimental and Developmental Therapeutics, School of Medicine, Indiana University, Indianapolis, IN, United States.
• ⁵ Center for Computational Biology and Bioinformatics, School of Medicine, Indiana University, Indianapolis, IN, United States.
• ⁶ Herman B Wells Center for Pediatric Research and Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, United States.
• ⁷ School of Medicine, Indiana University Bloomington, Bloomington, IN, United States.
• ⁸ Diabetes Center, University of California San Francisco, San Francisco, CA, United States.
• ⁹ Department of Surgery, University of California San Francisco, San Francisco, CA, United States.
• ¹⁰ Gladstone Institute of Genomic Immunology, University of California San Francisco, San Francisco, CA, United States.
• ¹¹ Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN, United States.
• ¹² Biochemistry & Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, United States.